MARCO A D ROCHA

Prof. MARCO A D ROCHA


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
EBEdileia Bagatin
Edileia Bagatin
TFThais Helena Proença de Freitas
Thais Helena Proença de Freitas
MRMaria Cecilia Rivitti-Machado
Maria Cecilia Rivitti-Machado
BRBeatriz Medeiros Ribeiro
Beatriz Medeiros Ribeiro
SNSamanta Nunes
Samanta Nunes
MRMARCO A D ROCHA
MARCO A D ROCHA
Keywords: Acne vulgaris; Adult; Advanced treatment; Consensus; Hormones; Hyperandrogenism; Skin; Therapeutics

17 November 2017 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
MRMARCO A D ROCHA
MARCO A D ROCHA
EBE. Bagatin
E. Bagatin

1 February 2018 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
MRMARCO A D ROCHA
MARCO A D ROCHA
EBEdiléia Bagatin
Ediléia Bagatin
Acne is a multifactorial and inflammatory disease of pilosebaceous follicles, which affects most adolescents. Recent epidemiological data revealed a difference in adults affected by this disease. Women have a high prevalence and incidence when compared with men, especially after 25 years of age. In contrast to what was initially thought, most of these patients do not present endocrinopathy capable of leading to the development of the lesions. When present, polycystic ovarian syndrome is the main cause. However, in these cases, acne is rarely the only dermatological manifestation; hirsutism and acanthosis nigricans are often present. The majority of the normoandrogenic acne patients present a history since adolescence, but in many cases the lesion distribution and intensity change with time. There is often a typical localization of the lesions in the lower third of the face and lateral region of the neck. Another interesting feature is related to the impact on quality of life (QoL), which is always intense. Often there are signs of depression, even when the lesions are mild. As most adult patients are women, in addition to the conventional options, there is also hormone treatment. Combined oral contraceptives and spironolactone are good options. Knowing more about the particularities in etiopathogenesis, impact on QoL, and specific treatment options is important to all dermatologists who face the challenge of treating acne in adults.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EBEdileia Bagatin
Edileia Bagatin
CCCaroline Sousa Costa
Caroline Sousa Costa
MRMARCO A D ROCHA
MARCO A D ROCHA
FPFabíola Rosa Picosse
Fabíola Rosa Picosse
CKCristhine Souza Leão Kamamoto
Cristhine Souza Leão Kamamoto
HMHelio Miot
Helio Miot
Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria. To communicate the experience and recommendation of Brazilian dermatologists on oral use of the drug in dermatology. Eight experts from five universities were appointed by the Brazilian Society of Dermatology to develop a consensus on indications for this drug. Through the adapted DELPHI methodology, relevant elements were listed and an extensive analysis of the literature was carried out. The consensus was defined with the approval of at least 70% of the experts. With 100% approval from the authors, there was no doubt about the efficacy of oral isotretinoin in the treatment of acne, including as an adjunct in the correction of scars. Common and manageable common adverse events are mucocutaneous in nature. Others, such as growth retardation, abnormal healing, depression, and inflammatory bowel disease have been thoroughly investigated, and there is no evidence of a causal association; they are rare, individual, and should not contraindicate the use of the drug. Regarding unapproved indications, it may represent an option in cases of refractory rosacea, severe seborrheic dermatitis, stabilization of field cancerization with advanced photoaging and, although incipient, frontal fibrosing alopecia. For keratinization disorders, acitretin performs better. In the opinion of the authors, indications for purely esthetic purposes or oil control are not recommended, particularly for women of childbearing age. Approved and non-approved indications, efficacy and adverse effects of oral isotretinoin in dermatology were presented and critically evaluated.

21 June 2014 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
RAR. G. R. Albuquerque
R. G. R. Albuquerque
MRMARCO A D ROCHA
MARCO A D ROCHA
EBE. Bagatin
E. Bagatin
STS. Tufik
S. Tufik
MAMonica Andersen
Monica Andersen

1 June 2014 in Inflammation & Allergy - Drug Targets
Verified
Journal Article
Closed access
PDF file
MRMARCO A D ROCHA
MARCO A D ROCHA
CCCaroline Sousa Costa
Caroline Sousa Costa
EBEdileia Bagatin
Edileia Bagatin
Acne is a chronic self-limited disease, which affects mostly teenagers, without gender difference. In recent years, the incidence has increased in female adults. The factors involved in this epidemiological observation are still under discussion in the literature. Clinically, acne is characterized by different types of lesions. The disease affects the regions rich in sebaceous glands (face, chest and upper back). The clinical lesions are: open and closed comedones, erythematous papules, pustules, nodules and different types of scars. Taking into consideration the general concept of inflammation (redness, pain, heat and loss of function), acne is traditionally classified as non-inflammatory (open and closed comedones) and inflammatory (other primary lesions). With the knowledge advancement this concept seems to be wrong and therefore acne would be an inflammatory disease even before the onset of their clinical lesions.